Building a Career in Marketing as a Biotech Student
The field of biotechnology is expansive, encompassing cutting-edge research, innovation, and the development of groundbreaking technologies. However, as a biotech student, you might find yourself drawn to the world of marketing, recognizing the need to communicate complex scientific ideas to…
Amgen Lays Off 350 Employees!
In a strategic move following its acquisition of Horizon Therapeutics for a staggering $27.8 billion, Amgen is undergoing significant organizational changes, resulting in the laying off 350 employees. This development was reported by various media outlets on Tuesday. The job…
The World’s Top Science Journalists of 2023:
Reporting Truth in the Age of Discovery In the ever-evolving landscape of journalism, science journalists play a pivotal role in bridging the gap between scientific advancements and the general public. In 2023, we find ourselves in a world where scientific…
New gene discovery for cancer patients unresponsive to chemotherapy
Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to…
Postdoctoral Scholar Position– Lasky Lab, Pennsylvania State University, USA
Postdoctoral Scholar – Lasky Lab: The Department of Biology at The Pennsylvania State University is seeking a motivated Postdoctoral Scholar to join the lab of Jesse R. Lasky. The lab studies how genetic diversity is created and preserved in species. This…
Groundbreaking long-acting monoclonal antibody, a collaborative effort between AstraZeneca (AZ) and Sanofi
On July 17, the U.S. Food and Drug Administration granted approval for nirsevimab, marketed under the name Beyfortus, as a groundbreaking (monoclonal antibody) preventive measure against Respiratory Syncytial Virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants during…
Breakthrough Chikungunya Vaccine of Valneva’s: Phase 3 trial Data
Valneva, a renowned global market leader in vaccine development, has published the research clinical data of its Chikungunya Vaccine candidate Phase 3, VLA1553. The groundbreaking results of VLA1553 can be found in the prestigious medical journal, The Lancet. With Chikungunya…
Enhancing Brain Cancer Treatment: Biodegradable Ultrasound Holds Promise
In the realm of brain cancer treatment, one of the major challenges lies in effectively delivering chemotherapy drugs through the tightly coiled blood vessels of the brain. However, a groundbreaking development in the form of a biodegradable ultrasound device could…
Blood test can now diagnose Glut1 deficiency syndrome
Glut1 deficiency syndrome is a rare and disabling neurological disease still relatively unknown to the medical community. A mutation in the SLC2A1 gene in affected patients causes the glucose transporter GLUT1 to malfunction. Since this transporter is responsible for the…
Engineering molecular interactions with machine learning
In 2019, scientists in the joint School of Engineering and School of Life Sciences Laboratory of Protein Design and Immunoengineering (LPDI) led by Bruno Correia developed MaSIF: a machine learning-driven method for scanning millions of protein surfaces within minutes to…
